- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03510026
Low Thermal Electrosurgical Device for Atraumatic Internal Thoracic Artery Harvesting
Skeletonized Internal Thoracic Artery Harvesting: A Low Thermal Electrosurgical Device Provides Improved Endothelial Layer and Better Integrity of the Vessel Wall
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Electrosurgery is fundamental to the precise, fast and bloodless preparation of internal thoracic artery grafts in cardiac surgery. The fundamental performance of electrosurgical dissection is created by using a continuous radiofrequency energy waveform, which thermally ablates soft tissue, leaving a collateral damage zone of 100-400 µm. The basic mechanism of tissue ablation and dissection in electrosurgery involves Joule heating of the conductive tissue by electric current, that leads to vaporization and ionization of the water content in the tissue adjacent to the electrode, and ultimately to vapor expansion and tissue fragmentation. Tissue heated below the vaporization threshold remains in place, but can undergo thermal denaturation determined by the temperature levels and duration of the hyperthermia. Thus, to confine the collateral damage zone in tissue, both of these factors should be minimized.
In contrast to continuous radiofrequency energy, pulsed electric waveforms with burst durations ranging from 10 to 100 µsec applied via an insulated planar electrode with 12 µm wide exposed edge produces a plasma-mediated, precise dissection of tissues with a lower collateral damage zone ranging from 2 to 10 µm. The greatly reduced zone of thermal damage, compared to conventional electrosurgical devices, may provide faster healing and less scarring.
The PEAK PlasmaBlade (Medtronic Advanced Energy, Portsmouth, NH USA) (FDA 510(k), CE-No. 540861, Model Number PS200-040) is an electrosurgical device that uses pulsed radiofrequency energy to generate a plasma-mediated discharge along the exposed rim of an insulated blade, creating an effective, precise cutting edge while the blade stays near body temperature. Plasma is an electrically conductive cloud created when the energy contacts tissue. This conductive cloud or "plasma" allows the radiofrequency energy to cross at much lower overall power levels. This use of less energy via plasma results in lower operating temperatures and less thermal damage. This technology has been shown to effectively dissect ophthalmologic and cutaneous tissues as precisely as a scalpel with the hemostatic control of conventional electrosurgery in clinical and experimental settings.
Concentrating on bypass grafts, the thoracic internal arteries (ITAs) demonstrate our most valuable conduit for revascularization of the coronary arteries. Compared to pedicled arteries, skeletonized ITAs have demonstrated a tendency to better long term patency. Additionally, skeletonized conduits are useful in expanding the number of anastomoses per patient and reducing the incidence of sternal complications.
The use of a dissection device that provides precise preparation, including optimal bleeding control without overly damaging the surrounding tissue, might be an optimizing factor for the protection of these valuable bypass grafts. The aim of this study was to compare the histological assessment, cardiac computed-tomography and clinical outcomes of patients following off-pump coronary artery bypass grafting with preparation of the ITAs by conventional electrosurgery and the PlasmaBlade.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all patients receiving elective coronary artery bypass grafting with both internal thoracic arteries
- signed consent
Exclusion Criteria:
- emergency procedures
- patients, who are already involved in other studies
- pregnant women or women of childbearing Age
- missing signed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Low thermal device preparation
One participant acts simultaneously as a control and active comparator.
One internal thoracic artery is prepared with the normal electrocautery device.
The other internal thoracic artery is prepared with the new low thermal device.
The participant does not know, which internal thoracic artery is defined to be prepared with the low thermal device.
|
One participant acts simultaneously as a control and active comparator.
One internal thoracic artery is prepared with the normal electrocautery device.
The other internal thoracic artery is prepared with the new low thermal device.
The participant does not know, which internal thoracic artery is defined to be prepared with the low thermal device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Endothelial damage
Time Frame: six months
|
Histological examination of internal thoracic artery samples stained for endothelial damage.
|
six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vessel wall integrity
Time Frame: six months
|
Histological examination of internal thoracic artery samples stained for vessel wall integrity.
|
six months
|
|
Patency of internal thoracic arteries as bypass grafts
Time Frame: six months
|
Computed tomography six months after bypass operation
|
six months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEK-ZH-Nr. 2013-0017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preparation of Internal Thoracic Artery
-
Johann Wolfgang Goethe University HospitalKlinikum LudwigshafenCompletedComplications Due to Coronary Artery Bypass Graft | Injury of Internal Mammary ArteryGermany
-
University of British ColumbiaCompletedEfficacy of Bowel Preparation | Ease of Bowel Preparation and Patient TolerabilityCanada
-
University College, LondonCompletedPeriodontitis | Intimal Medial Thickness of Internal Carotid ArteryUnited Kingdom
-
Northwestern UniversityCompletedSurgical Preparation of the VaginaUnited States
-
Samsung Medical CenterUnknownEffect of Shoulder Traction on Size and Relative Position of Internal Jugular Vein to Carotid ArteryInfants | Internal Jugular Vein Cannulation | Common Carotid ArteryKorea, Republic of
-
LanZhou UniversityNot yet recruitingColonoscopy | Bowel Preparation | Quality of HealthcareChina
-
Atlantic Health SystemTerminatedSimulation for Preparation of Robotic SurgeryUnited States
-
Meshalkin Research Institute of Pathology of CirculationCompletedStenosis, Internal Carotid ArteryRussian Federation
-
Shanghai Changzheng HospitalRenJi HospitalNot yet recruitingQuality of Small Bowel Preparation
-
Karolinska InstitutetCompletedPatient Satisfaction and Efficacy of Bowel-preparationSweden
Clinical Trials on Low thermal device preparation
-
Sheffield Children's NHS Foundation TrustCompleted
-
Rhaeos, Inc.Recruiting
-
UMay Care Inc.UnknownMeibomian Gland Dysfunction | Dry Eye Disease
-
Rhaeos, Inc.Not yet recruiting
-
CoolTech LLCCompletedFever | Seizures | Stroke, Ischemic | Stroke Hemorrhagic | Metabolic EncephalopathyUnited States
-
Rhaeos, Inc.RecruitingHydrocephalusUnited States
-
Rhaeos, Inc.Completed
-
Rhaeos, Inc.Completed
-
Basic Health International, Inc.The Cleveland Clinic; Medical College of Wisconsin; Liger Medical LlcRecruitingCervical Intraepithelial Neoplasia | Human Papillomavirus Infection | Cervical PrecancerEl Salvador
-
Rhaeos, Inc.National Institute of Neurological Disorders and Stroke (NINDS)Not yet recruitingHydrocephalusUnited States